Chemistry of Covalent Binding: Studies with Bromobenzene and Thiobenzamide

  • Robert P. Hanzlik
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 197)


The concept that chemically reactive metabolites of foreign substances could react covalently with cellular constituents to cause biological injury was introduced by J. A. Miller and E. C. Miller almost 40 years ago. 1–3 Since then considerable effort has been spent investigating the chemistry, biochemistry and biological consequences of reactive metabolic intermediates. Our laboratory has been interested in the metabolic activation, covalent binding and hepatotoxicity of two relatively simple organic compounds, bromobenzene and thiobenzamide. Our long term objective has been to determine the identity of their reactive metabolites, the chemistry of their covalent binding to cellular macromolecules and the relationship of the various types of covalent binding events to the biological changes which follow. This report summarizes some of our recent efforts toward these objectives.


Covalent Binding Butylate Hydroxy Toluene Substituent Effect Reactive Metabolite Tritiated Water 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E. C. Miller and J. A. Miller, The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 7: 468–480 (1947).Google Scholar
  2. 2.
    E. C. Miller and J. A. Miller, In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis. Cancer Res. 12: 547–556 (1952).Google Scholar
  3. 3.
    J. A. Miller, Carcinogenesis by chemicals: an overview. Cancer Res. 30: 559–576 (1970).PubMedGoogle Scholar
  4. 4.
    B. B. Brodie, W. D. Reid, A. K. Cho, G. Sipes, G. Krishna and J. R. Gillette, Possible mechanism of liver necrosis caused by aranatic organic compounds. Proc. Nat. Acad. Sci. (U.S.), 68: 160–164 (1971).CrossRefGoogle Scholar
  5. 5.
    D. J. Jollow, J. R. Mitchell, N. Zampaglione and J. R. Gillette, Branobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite, Pharmacology. 11: 151–169 (1974).PubMedCrossRefGoogle Scholar
  6. 6.
    S. Hesse, T. Wolf and M. Mezger, Involv orient of phenolic metabolites in the irreversible protein-binding of 14C-branobenzene catalyzed by rat liver microsomes. Arch. Toxicol., Suppl. 4, 358–362 (1980).CrossRefGoogle Scholar
  7. 7.
    J. W. Dodgson, The reaction of p-benzoquinone with sulphurous acid and with alkali. Part I. J. Chem. Soc., 105: 2435–2443 (1914).CrossRefGoogle Scholar
  8. 8.
    K. T. Finley, The addition-substitution chemistry of quinones, in: “The chemistry of quinoid compounds, S. Patai, ed., John Wiley and Sons, New York (1974), pp 880–900.Google Scholar
  9. 9.
    T. J. Monks, L. R. Pohl, J. R. Gillette, M. Hong, R. J. Highet, J. A. Ferrretti and J. A. Hinson, Stereoselective formation of two bromobenzene-glutathione conjugates. Chem.-Biol. Interactions 41: 203–216 (1982).Google Scholar
  10. 10.
    R. P. Hanzlik, K. Hogberg and C. M. Judson, Microsomal hydroxylation of specifically deuterated monosubstituted benzenes. Evidence for direct aromatic hydroxylation. Biochemistry 23: 3048–3055 (1984).PubMedCrossRefGoogle Scholar
  11. 11.
    J. W. Daly, D. M. Jerina and B. Witkop, Arene oxides and the NIHshift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 28: 1129–1149 (1972).PubMedCrossRefGoogle Scholar
  12. 12.
    R. P. Hanzlik and J. R. Cashman, Micrrosomal metabolism of thioben-zamide and thiobenzamide S-oxide. Drug Metab. Disposition, 11: 201–205 (1983).Google Scholar
  13. 13.
    R. E. Tynes and E. Hodgson, Oxidation of thiobenzamide by the FAD-containing and cytochrome P-450-dependent monooxygenases of liver and lung microsomes. Biochen. Pharmacol. 33: 3419–3428 (1983).CrossRefGoogle Scholar
  14. 14.
    M. Younes, Involvanent of reactive oxygen species in the microsomal S-oxidation of thiobenzamide. Experientia, 41: 479–480 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    J. R. Cashman and R. P. Hanzlik, Oxidation and other reactions of thiobenzamide derivatives of relevance to their hepatotoxicity. J. Org. Chem. 47: 4645–4650 (1982).CrossRefGoogle Scholar
  16. 16.
    R. P. Hanzlik, J. R. Cashman and G. J. Traiger, Relative hepatotoxicityof substituted thiobenzamides and thiobenzamide S-oxides in the rat. Toxicol. Appl. Pharmacol. 55: 260–272 (1980).PubMedCrossRefGoogle Scholar
  17. 17.
    J. R. Cashman, K. K. Parikh, G. J. Traiger and R. P. Hanzlik, Relative hepatotoxicity of ortho and meta monosubstituted thiobenzamides in the rat. Chem.-Biol. Interactions 45: 341–347 (1983).Google Scholar
  18. 18.
    J. R. Cashman, G. J. Traiger and R. P. Hanzlik, Pneumotoxic effects of thiobenzamide derivatives. Toxicology, 23: 85–93 (1982).PubMedCrossRefGoogle Scholar
  19. 19.
    R. P. Hanzlik, K. P. Vyas and G. J. Traiger, Substituent effects on the hepatotoxicity of thiobenzamide derivatives in the rat. Toxicol. Appl. Pharmacol., 46: 685–694 (1978).PubMedCrossRefGoogle Scholar
  20. 20.
    J. R. Cashman, Ph.D. Thesis, University of Kansas, 1982.Google Scholar
  21. 21.
    D. W. Gottschall, D. A. Penney, G. J. Traiger and R. P. Hanzlik, Oxidation of N-methylthiobenzamide and N-methylthiobenzamide S-oxide by liver and lung microsomes. Toxicol. Appl. Pharmacol., 78: 332–341 (1985).PubMedCrossRefGoogle Scholar
  22. 22.
    D. A. Penney, D. W. Gottschall, R. P. Hanzlik and G. J. Traiger, The role of metabolism in N-methylthiobenzamide-induced pneunotoxicity. Toxicol. Appl. Pharmacol. 78: 323–331 (1985).PubMedCrossRefGoogle Scholar
  23. 23.
    M. H. Griffiths, J. A. Moss, J. A. Rose, and D. E. Hathway, The comparative metabolism of 2,6-dichlorothiobenzamide (Prefix) and 2,6-dichlorothiobenzonitrile in the dog and rat. Biochem. J. 98: 770–781 (1966).PubMedGoogle Scholar
  24. 24.
    R. P. Hanzlik, Effects of substituents of reactivity and toxicity of chemically reactive intermediates. Drug Metab. Rev. 13: 207–234 (1982).Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Robert P. Hanzlik
    • 1
  1. 1.Department of Medicinal ChemistryUniversity of Kansas LawrenceUSA

Personalised recommendations